Related Experiment Video
Updated: Jun 17, 2026

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
DNA and mRNA vaccines: Significant therapeutic approach against cancer management
Aniruddha Sen1, Vijay Singh1, Sumel Ashique2
1Department of Biochemistry, All India Institute of Medical Sciences, Gorakhpur, Uttar Pradesh, India.
Abstract:
Cancer's complex nature and personal variety make it among the toughest cancers to conquer. Innovative treatment strategies can be achieved through new biotechnology developments. DNA and mRNA vaccinations deliver an opportunity to take a new path for cancer. The ways in which DNA and mRNA vaccinations generate immune reactions that specifically focus on cancer cells are discussed in this section. This chapter focuses on the development and creation of these vaccines. We will focus on the latest research that proves the effectiveness of these vaccines and their safety over different types of cancer. Also, we discuss the technological and biological barriers in the process of vaccine development that hinder the development of these vaccines, such as the stability of delivery methods and a patient-specific design for vaccines. DNA and mRNA vaccinations are an important therapeutic approach against cancer with genetic information. They offer an opportunity for the future to develop tailored as well as more efficient treatment options.
Insights
DNA and mRNA vaccines represent a promising frontier in cancer treatment, harnessing genetic information to stimulate targeted immune responses against cancer cells. Ongoing research highlights their potential efficacy and safety across various cancer types, despite developmental challenges.
Area of Science:
- Biotechnology
- Immunology
- Oncology
Background:
- Cancer presents a complex and heterogeneous challenge in treatment.
- Biotechnology advancements offer novel therapeutic strategies.
- DNA and mRNA vaccines are emerging as a new approach in cancer therapy.
Purpose of the Study:
- To explore the development and mechanisms of DNA and mRNA cancer vaccines.
- To review current research on the effectiveness and safety of these vaccines.
- To identify technological and biological barriers in vaccine development.
Main Methods:
- Review of recent scientific literature on DNA and mRNA cancer vaccines.
- Analysis of immune response generation by these vaccine platforms.
- Discussion of challenges including delivery stability and personalized vaccine design.
Main Results:
- DNA and mRNA vaccines can elicit targeted immune responses against cancer cells.
- Evidence suggests potential efficacy and safety across diverse cancer types.
- Key challenges include ensuring delivery method stability and patient-specific design.
Conclusions:
- DNA and mRNA vaccinations are significant therapeutic modalities for cancer treatment.
- These vaccines offer a future pathway for personalized and more effective cancer therapies.
- Overcoming developmental hurdles is crucial for realizing their full potential.
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Microorganisms in Medicine and Therapeutics
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

